Drug intelligence / Profile preview

TGFP

Development stage
Unknown
Lead developer
China Medical University Hospital
Administration
Oral
01

Overview

TGFP (also referred to as TGF) is an herbal formula based on the traditional Chinese medicine **Hu-Qian Wan** (Hidden Tiger Pill), which is being developed by **China Medical University Hospital** for the treatment of **knee osteoarthritis**. The formula is a multi-ingredient botanical product traditionally used to nourish kidney yin and strengthen bones and tendons. In clinical studies, TGFP is being evaluated for its ability to reduce pain and improve joint function by modulating biochemical markers associated with cartilage degradation and inflammation, such as interleukin-1 (IL-1), interleukin-6 (IL-6), matrix metalloproteinases (MMP-3, MMP-13), and ADAMTS-4. The formula typically contains ingredients such as Phellodendri Chinensis Cortex, Anemarrhenae Rhizoma, and Rehmanniae Radix Praeparata.

Brand names
Hu-Qian Wan
Other names
Hidden Tiger PillHuqian Wan
02

Targets

ADAMTS4 (ADAM metallopeptidase with thrombospondin type 1 motif 4)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)MMP13 (Matrix metalloproteinase-13)MMP3 (Matrix metalloproteinase-3)TGM2 (Tissue Transglutaminase 2)IL1A (Interleukin 1 alpha)

Beyond the preview

Go deeper on TGFP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TGFP.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call